These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3361425)

  • 1. Prodrugs utilizing organosilyl derivation: an investigation of the long-term androgenic and myotrophic activities of silyl derivatives of testosterone.
    Millership JS; Shanks ML
    J Pharm Sci; 1988 Feb; 77(2):116-9. PubMed ID: 3361425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of steroids with antiandrogenic properties on androgenic and myotrophic activity of testosterone and some of its derivatives.
    Ivanenko TI
    Neurosci Behav Physiol; 1980; 10(3):227-31. PubMed ID: 7413078
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of steroids with anti-androgenic properties on the androgenic and myotrophic activity of testosterone and its various derivatives].
    Ivanenko TI
    Probl Endokrinol (Mosk); 1978; 24(4):86-91. PubMed ID: 683979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations on steroids. IX. Pharmacological studies. (3). Myotrophic and androgenic activities of 17beta-hydroxy-5alpha-androstano-[2,3-c]furazan and its derivatives.
    Kasahara A; Onodera T; Oshima Y; Shimizu M
    Chem Pharm Bull (Tokyo); 1968 Aug; 16(8):1456-9. PubMed ID: 5708248
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and myotrophic-androgenic activity of 17beta-hydroxy-5alpha-androst-8(14)-en-3-one derivatives.
    Wolff ME; Chang HH
    J Med Chem; 1970 Sep; 13(5):967-8. PubMed ID: 5458391
    [No Abstract]   [Full Text] [Related]  

  • 6. Androgenic and myotrophic properties of orally administered 9-fluoro-11-oxymethyltestosterones.
    LYSTER SC; LUND GH; STAFFORD RO
    Endocrinology; 1956 Jun; 58(6):781-5. PubMed ID: 13330678
    [No Abstract]   [Full Text] [Related]  

  • 7. Anabolic and androgenic activities, in rat, of some nandrolone and androstanolone esters.
    Chaudry MA; James KC; Ng CT; Nicholls PJ
    J Pharm Pharmacol; 1976 Dec; 28(12):882-5. PubMed ID: 12263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-androgenic activity of 7,8,9,10-tetra-hydro-7-oxo-benzo (c) phenanthridine (A11-IV) on immature, castrated, male rats.
    Saksena SK; Chaudhury RR
    J Reprod Fertil; 1970 Apr; 21(3):559-61. PubMed ID: 5442325
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and biological activity of some ethers of testosterone. Implications concerning the biological activity of esters of testosterone.
    Solo AJ; Bejba N; Hebborn P; May M
    J Med Chem; 1975 Feb; 18(2):165-8. PubMed ID: 1120983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the skin resorptive action of testosterone and its esters].
    Fedorov VK; Shashkina LF
    Farmakol Toksikol; 1975; 38(5):596-9. PubMed ID: 1183593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative evaluation of the dose-response relationship after intramuscular administration of testosterone and its esters].
    Fedorov VK; Shashkina LF; Liberman MD
    Probl Endokrinol (Mosk); 1976; 22(4):92-7. PubMed ID: 1028048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biological activity of 7 alpha-methyl-19-nortestosterone is not amplified in male reproductive tract as is that of testosterone.
    Kumar N; Didolkar AK; Monder C; Bardin CW; Sundaram K
    Endocrinology; 1992 Jun; 130(6):3677-83. PubMed ID: 1597164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of testosterone and prolactin or growth hormone on the accessory sex organs of castrated mice.
    Keenan EJ; Thomas JA
    J Endocrinol; 1975 Jan; 64(1):111-5. PubMed ID: 1117214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biological activity of dimeric testosterone, a new long-acting androgen, and of testosterone enanthate in the castrated male rat.
    Kuhl H; Braun J; Dericks-Tan JS; Taubert HD
    Horm Res; 1979; 10(5):252-67. PubMed ID: 457037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative androgenic, myotrophic and antigonadotrophic properties of some anabolic steroids.
    Boris A; Stevenson RH; Trmal T
    Steroids; 1970 Jan; 15(1):61-71. PubMed ID: 5410669
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of androgen and estradiol administration on the weight of the ventral prostate, seminal vesicles, and testes of immature rats.
    Jackson AC; Tenniswood M; Bird CE; Clark AF
    Invest Urol; 1977 Mar; 14(5):351-55. PubMed ID: 844996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietic activity and androgenic implications of 29 testosterone derivatives in orchiectomized rats.
    Molinari PF; Rosenkrantz H
    J Lab Clin Med; 1971 Sep; 78(3):399-410. PubMed ID: 5092861
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of myotrophic and androgenic activities of 19-nortestosterone cyclopentylpropionate, androstanolone, and methylandrostenediol.
    BARNES LE; STAFFORD RO; GUILD ME; OLSON KJ
    Proc Soc Exp Biol Med; 1954 Oct; 87(1):35-8. PubMed ID: 13224668
    [No Abstract]   [Full Text] [Related]  

  • 19. Dissociation of anabolic and androgenic properties of steroids by anti-anabolic and anti-androgenic agents in rats.
    Steinetz BG; Giannina T; Butler M; Popick
    Endocrinology; 1971 Sep; 89(3):894-6. PubMed ID: 5566400
    [No Abstract]   [Full Text] [Related]  

  • 20. Anabolic agents. 2,3-Epithioandrostane derivatives.
    Klimstra PD; Nutting EF; Counsell RE
    J Med Chem; 1966 Sep; 9(5):693-7. PubMed ID: 5969041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.